Managed Healthcare Executive1 天
FDA Adds Boxed Warning to Veozah Label
The boxed warning follows a safety warning the FDA issued in September about the risk of liver injury from the use of Veozah ...
FDA Issues Vet Letter on Drug Librela Used to Control Pain in Dogs
The FDA's Center for Veterinary Medicine posted a letter alerting veterinarians of adverse health effects in dogs from ...
FiercePharma3 天
FDA blesses atopic dermatitis label expansions for Organon's Vtama, Galderma's Nemluvio
The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).
PMLiVE23 小时
FDA approves Organon’s Vtama cream to treat atopic dermatitis in adults and children
The US Food and Drug Administration (FDA) has approved Organon’s Vtama (tapinarof) cream, 1% to treat atopic dermatitis in ...
oncnursingnews1 天
FDA Approves First MSC Therapy in Steroid-Refractory GVHD
FDA gives nod of approval to first derived mesenchymal stromal cell therapy for the treatment of pediatric patients with ...
Targeted Oncology1 天
FDA Approves Ensartinib in ALK-Positive NSCLC
Ensartinib has received FDA approval for the first-line treatment of anaplastic lymphoma kinase (ALK)-positive locally ...
The American Journal of Managed Care4 天
FDA Approves Tapinarof Cream 1% for Patients With Atopic Dermatitis
2 “With the FDA’s approval of VTAMA cream in AD for adults and children as young as 2 years old, there is now a therapy that ...
oncnursingnews1 天
FDA Approves Ensartinib To Treat Frontline ALK+ NSCLC
Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...
Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug
We believe there is enormous opportunity for us in the animal pharmaceuticals market, as there is a significant need to deliver medications more efficiently,” Gelteq co-founder and CEO Nathan Givoni ...